Programme Members

Programme Contacts

University of Cambridge
Department of Haematology
University of Cambridge
Department of Haematology
Department of Haematology
Programme Manager

Selected publications

Principal investigators and consultants

  • All members
  • Group leaders
  • Clinical consultants
University of Cambridge
Department of Haematology
Using a novel proteomic technique, plasma membrane profiling, we aim to determine the cell surface proteome of myeloma cell lines, as well...
PI:
N
CC:
N
Characterization of leukaemogenic regulatory networks in Acute Myeloid Leukaemia
PI:
N
CC:
N
University of Cambridge
Department of Haematology
The Cambridge Blood and Stem Cell Biobank is a facility of over 6000 viable and nucleic acid samples, the majority from patients with...
PI:
Y
CC:
N
PhD student in Haematology
PI:
N
CC:
N
University of Cambridge
School of Clinical Medicine, Department of Haematology
PI:
N
CC:
N
Department of Haematology
Wellcome Trust MRC Cambridge Stem Cell Institute
PI:
N
CC:
N
University of Cambridge
Department of Haematology
Wellcome Trust MRC Cambridge Stem Cell Institute
I focus my research in the study of the transcriptional networks that control stem cell differentiation and how their perturbation can lead...
PI:
N
CC:
N
Wellcome Trust Sanger Institute
Cancer Genetics and Genomics
Dr Peter Campbell is Head of Cancer, Ageing and Somatic Mutation, and Senior Group Leader at the Sanger Institute and is joint head of the...
PI:
Y
CC:
Y
University of Cambridge
Department of Haematology
National Blood Service
Our long-term aim is to understand the interplay between the myriad pathways involved in the pathogenesis of multiple myeloma so that these...
PI:
Y
CC:
Y
Cambridge University Hospitals NHS Foundation Trust
Department of Haematology
.
PI:
N
CC:
Y
Department of Haematology
Wellcome Trust MRC Cambridge Stem Cell Institute
(tbc)
PI:
N
CC:
N
University of Cambridge
Department of Pathology
Lymphomas are a group of highly heterogeneous tumors derived from B or T lymphocytes and occur at both nodal and extranodal sites. The...
PI:
Y
CC:
Cambridge University Hospitals NHS Foundation Trust
Department of Haematology
.
PI:
N
CC:
Y
University of Cambridge
Department of Haematology
Cambridge Institute for Medical Research
PI:
N
CC:
N
Cambridge University Hospitals NHS Foundation Trust
Department of Haematology
My laboratory research focuses on transcriptional regulation and chromatin structure. I maintain a supervisory role for a research...
PI:
N
CC:
Y
Cambridge University Hospitals NHS Foundation Trust, University of Cambridge
Department of Haematology
Wellcome Trust MRC Cambridge Stem Cell Institute, Cambridge Institute for Medical Research
Honorary Consultant Cambridge University Hospitals NHS Trust
My research interests focus on mechanisms of disease initiation and maintenance and the identification and validation of novel therapeutic...
PI:
Y
CC:
Y
Department of Haematology
PI:
N
CC:
N
University of Cambridge
Department of Haematology
Wellcome Trust MRC Cambridge Stem Cell Institute
Consultant Haematologist
Cedric Gevaert graduated from the medical school of the University Libre de Bruxelles in 1997 and subsequently became a fellow of the Royal...
PI:
N
CC:
N
AstraZeneca
Clinical Pharmacology and Safety Sciences
Safety assessment of oncology drugs (and combinations) with particular focus on the bone marrow.
PI:
N
CC:
N
University of Cambridge
Department of Haematology
Wellcome Trust MRC Cambridge Stem Cell Institute
The Göttgens group uses a combination of experimental and computational approaches to study how transcription factor networks control the...
PI:
Y
CC:
Cambridge University Hospitals NHS Foundation Trust
Department of Pathology
.
PI:
N
CC:
Y
University of Cambridge
Department of Haematology
Cambridge Institute for Medical Research, Wellcome Trust MRC Cambridge Stem Cell Institute
The JAK/STAT pathway has essential roles in several aspects of metazoan biology including haematopoiesis and stem cell function. Somatic...
PI:
Y
CC:
Y
University of Cambridge
Cancer Research UK Cambridge Institute
Flow cytometry core facility
PI:
N
CC:
N
University of Cambridge
Department of Haematology
Wellcome Trust MRC Cambridge Stem Cell Institute
PI:
N
CC:
N
Department of Pathology
PI:
N
CC:
N
Department of Haematology
Wellcome Trust MRC Cambridge Stem Cell Institute
PI:
N
CC:
N
University of Cambridge
Department of Haematology
Wellcome Trust MRC Cambridge Stem Cell Institute
Addenbrooke's Haematology
Pathogenesis of Germinal Centre Derived B Cell Lymphomas. Many of the commonest human lymphomas (including follicular, diffuse large B cell...
PI:
Y
CC:
Y
University of Cambridge
Department of Haematology
Cambridge Institute for Medical Research
Our aim is to further characterise the molecular and cellular biology of cancer stem cells and to compare and contrast these to normal stem...
PI:
Y
CC:
Y
University of Cambridge
Department of Haematology
Wellcome Trust MRC Cambridge Stem Cell Institute
My research focuses on normal and malignant blood stem cell biology.  Specifically, I am interested in understanding stem cell...
PI:
Y
CC:
N
Department of Haematology, MRC Cancer Unit
Wellcome Trust MRC Cambridge Stem Cell Institute
PI:
N
CC:
N
University of Cambridge
Department of Haematology
Daily blood cell production is guaranteed throughout life by a hierarchy with haematopoietic stem cells (HSC) at its root. HSC are very...
PI:
Y
CC:
N
Department of Haematology
Wellcome Trust MRC Cambridge Stem Cell Institute
Programme Manager for Haematological Malignancies Programme.
PI:
N
CC:
N
University of Cambridge
Department of Physiology, Development and Neuroscience
PI:
Y
CC:
Department of Haematology
PI:
N
CC:
N
University of Cambridge
Department of Haematology
Wellcome Trust MRC Cambridge Stem Cell Institute
PI:
N
CC:
N
University of Cambridge
Department of Haematology
Wellcome Trust MRC Cambridge Stem Cell Institute
NHS-Blood and Transplant
The Méndez-Ferrer laboratory research focuses on the regulation of the haematopoietic stem-cell niche in health and disease. Blood stem...
PI:
N
CC:
N
Acute myeloid leukemia (AML) is a molecularly diverse malignancy representing 15-20% of all childhood and around 35% of all adult leukemias...
PI:
N
CC:
N
Fate choice in normal and malignant haematopoietic stem cells http://www.stemcells.cam.ac.uk/researchers/principal-investigators/dr-da...
PI:
Y
CC:
N
University of Cambridge, Babraham Institute
Department of Pathology
Phosphoinositide 3-kinases (PI3Ks) are enzymes that act downstream of tyrosine kinase signalling and generate second messenger signalling...
PI:
Y
CC:
N
Wellcome Trust Sanger Institute
Virus genomics
Genomics of the oncogenic viruses Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus and their associated tumours.
PI:
N
CC:
N
Department of Haematology
PI:
N
CC:
N
University of Cambridge
Department of Haematology
We aim to understand the role of transcriptional noise in normal and malignant cell fate decisions, and to explore candidate noise...
PI:
Y
CC:
N
University of Cambridge, Cambridge University Hospitals NHS Foundation Trust
Department of Haematology
We study the interaction between malignant B cells and cells of the microenvironment to understand signalling pathways mediating the...
PI:
Y
CC:
Y
University of Cambridge
Department of Haematology
Wellcome Trust MRC Cambridge Stem Cell Institute
The central aim of this PhD project is to characterise alterations in the niche of HSC, imposed by malignant B cells, and to understand...
PI:
N
CC:
N
Department of Haematology
Wellcome Trust MRC Cambridge Stem Cell Institute
PI:
N
CC:
N
The molecular processes which control the development and function of lymphocytes have been extensively studied from the perspective of...
PI:
N
CC:
N
Wellcome Trust Sanger Institute, University of Cambridge
Department of Haematology
Wellcome Trust MRC Cambridge Stem Cell Institute
Haematological Cancer Genetics Group
I am a CR-UK Senior Clinical Fellow and a member of Faculty at the Wellcome Sanger and Wellcome-MRC Cambridge Stem Cell Institutes. My...
PI:
Y
CC:
Y
University of Cambridge
Department of Haematology
Cambridge Institute for Medical Research
Haematology
Our long-term goal is to elucidate the molecular mechanisms of ribosome assembly in eukaryotic cells and to understand how defects in this...
PI:
Y
CC:
Y
(tbc)
PI:
N
CC:
N
(tbc)
PI:
N
CC:
N